Stay updated with breaking news from Dan Levine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NV5 Global, Inc. (NASDAQ:NVEE) Q4 2023 Earnings Call Transcript February 22, 2024 NV5 Global, Inc. misses on earnings expectations. Reported EPS is $1.14 EPS, expectations were $1.22. NV5 Global, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
The attorney general for one of the most populous U.S. states this week urged federal drug regulators to address safety risks associated with the widely used asthma and allergy medicine Singulair,...
The attorney general for one of the most populous U.S. states this week urged federal drug regulators to address safety risks associated with the widely used asthma and allergy medicine Singulair, saying current warnings on the drug's packaging are insufficient, particularly for children. In a letter dated on Wednesday, the New York state attorney general's office urged the U.S. Food and Drug Administration to further investigate and warn consumers and healthcare providers about harmful neuropsychiatric side effects of Singulair, also known by its generic name montelukast. The offi...
NV5 Global, Inc. misses on earnings expectations. Reported EPS is $1.14 EPS, expectations were $1.22. NV5 Global, Inc.
Hellohive announced on Thursday a $3.4 million Series A round to help combat discrimination during the hiring process.